References
1. Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of
cancer treatment: a pilot study assessing out-of-pocket expenses and the
insured cancer patient’s experience. The oncologist.2013;18(4):381.
2. Carrera PM, Kantarjian HM, Blinder VS. The financial burden and
distress of patients with cancer: understanding and stepping‐up action
on the financial toxicity of cancer treatment. CA: a cancer
journal for clinicians. 2018;68(2):153-165.
3. Fenn KM, Evans SB, McCorkle R, et al. Impact of financial burden of
cancer on survivors’ quality of life. Journal of oncology
practice. 2014;10(5):332-338.
4. Huang I-C, Bhakta N, Brinkman TM, et al. Determinants and
consequences of financial hardship among adult survivors of childhood
cancer: a report from the St. Jude Lifetime Cohort Study. JNCI:
Journal of the National Cancer Institute. 2019;111(2):189-200.
5. Kale HP, Carroll NV. Self‐reported financial burden of cancer care
and its effect on physical and mental health‐related quality of life
among US cancer survivors. Cancer. 2016;122(8):283-289.
6. Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D.
Association of financial strain with symptom burden and quality of life
for patients with lung or colorectal cancer. Journal of Clinical
Oncology. 2016;34(15):1732.
7. Ramsey SD, Bansal A, Fedorenko CR, et al. Financial insolvency as a
risk factor for early mortality among patients with cancer.Journal of Clinical Oncology. 2016;34(9):980.
8. Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D.
Population-based assessment of cancer survivors’ financial burden and
quality of life: a prospective cohort study. Journal of oncology
practice. 2015;11(2):145-150.
9. Guy Jr GP, Ekwueme DU, Yabroff KR, et al. Economic burden of cancer
survivorship among adults in the United States. Journal of
Clinical Oncology. 2013;31(30):3749.
10. Holshue ML, DeBolt C, Lindquist S, et al. First Case of 2019 Novel
Coronavirus in the United States. New England Journal of
Medicine. 2020;382(10):929-936.
11. Wu Z, McGoogan JM. Characteristics of and Important Lessons From the
Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a
Report of 72 314 Cases From the Chinese Center for Disease Control and
Prevention. JAMA. 2020.
12. Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the
COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast
During an Emergency Response. JAMA. 2020.
13. Anderson RM, Heesterbeek H, Klinkenberg D, Hollingsworth TD. How
will country-based mitigation measures influence the course of the
COVID-19 epidemic? The Lancet. 2020;395(10228):931-934.
14. Hafiz H, Oei S-Y, Ring DM, Shnitser N. Regulating in Pandemic:
Evaluating Economic and Financial Policy Responses to the Coronavirus
Crisis. Boston College Law School Legal Studies Research Paper.2020(527).
15. Brenan M. U.S. Employees Increasingly Seeing COVID-19 Effects at
Work. Gallup. 2020.
https://news.gallup.com/poll/305237/employees-increasingly-seeing-covid-effects-work.aspx.
. Accessed March 31, 2020.
16. Yu J, Ouyang W, Chua MLK, Xie C. SARS-CoV-2 Transmission in Patients
With Cancer at a Tertiary Care Hospital in Wuhan, China. JAMA
Oncology. 2020.
17. Liang W, Guan W, Chen R, et al. Cancer patients in SARS-CoV-2
infection: a nationwide analysis in China. The Lancet Oncology.2020;21(3):335-337.
18. Jacobson JJ, Epstein JB, Eichmiller FC, et al. The cost burden of
oral, oral pharyngeal, and salivary gland cancers in three groups:
commercial insurance, Medicare, and Medicaid. Head Neck Oncol.2012;4:15.
19. Position Statement: Otolaryngologists and the COVID-19 Pandemic.American Academy of Otolaryngology-Head and Neck Surgery 2020;
https://www.entnet.org/content/otolaryngologists-and-covid-19-pandemic.
Accessed April 1, 2020.
20. Chan JYK, Wong EWY, Lam W. Practical Aspects of Otolaryngologic
Clinical Services During the 2019 Novel Coronavirus Epidemic: An
Experience in Hong Kong. JAMA Otolaryngology–Head & Neck
Surgery. 2020.
21. Saibene AM, Allevi F, Biglioli F, Felisati G. Role and management of
a head and neck department during the COVID-19 Outbreak in Lombardy.Otolaryngology—Head and Neck Surgery. 2020.
22. Information for Head and Neck Oncologists During the COVID-19
Pandemic (from the Survivorship, Supportive Care & Rehabilitation
Service). 2020;
https://www.ahns.info/wp-content/uploads/2020/03/synthesized-physician-doc.pdf.
Accessed April 4, 2020.
23. Academy Supports CMS, Offers Specific Nasal Policy. 2020;
https://www.entnet.org/content/academy-supports-cms-offers-specific-nasal-policy.
Accessed April 4, 2020.
24. Ueda M, Martins R, Hendrie PC, et al. Managing cancer care during
the COVID-19 pandemic: Agility and collaboration toward a common goal.Journal of the National Comprehensive Cancer Network.2020;1(aop):1-4.
25. Jazieh A-R, Hadab AA, Olayan AA, et al. Managing Oncology Services
During a Major Coronavirus Outbreak: Lessons From the Saudi Arabia
Experience. JCO Global Oncology. 2020(6):518-524.
26. Cornwall W. Can you put a price on COVID-19 options? Experts weigh
lives versus economics. In. Science 2020.
27. Correia S, Luck S, Verner E. Pandemics Depress the Economy, Public
Health Interventions Do Not: Evidence from the 1918 Flu. SSRN.2020;Pre-print.
28. Hone T, Mirelman AJ, Rasella D, et al. Effect of economic recession
and impact of health and social protection expenditures on adult
mortality: a longitudinal analysis of 5565 Brazilian municipalities.Lancet Glob Health. 2019;7(11):e1575-e1583.
29. Sullivan D, von Wachter T. Job Displacement and Mortality: An
Analysis Using Administrative Data*. The Quarterly Journal of
Economics. 2009;124(3):1265-1306.
30. Ruhm CJ. Recessions, healthy no more? Journal of Health
Economics. 2015;42:17-28.
31. Cox J. Coronavirus job losses could total 47 million, unemployment
rate may hit 32%, Fed estimates. CNBC. 2020.
https://www.cnbc.com/2020/03/30/coronavirus-job-losses-could-total-47-million-unemployment-rate-of-32percent-fed-says.html.
Accessed April 1, 2020.
32. Unemployment Insurance Weekly Claims Report April 2, 2020. In: Labor
USDo, ed2020.
33. Gordon LG, Merollini KMD, Lowe A, Chan RJ. A Systematic Review of
Financial Toxicity Among Cancer Survivors: We Can’t Pay the Co-Pay.Patient. 2017;10(3):295-309.
34. de Souza JA, Kung S, O’Connor J, Yap BJ. Determinants of
Patient-Centered Financial Stress in Patients With Locally Advanced Head
and Neck Cancer. J Oncol Pract. 2017;13(4):e310-e318.
35. Casselman B, Cohen P, Cowley S, et al. Coronavirus Cost to
Businesses and Workers: ‘It Has All Gone to Hell’. The New York
Times. March 15, 2020, 2020.
36. Mady LJ, Lyu L, Owoc MS, et al. Understanding financial toxicity in
head and neck cancer survivors. Oral Oncol. 2019;95:187-193.
37. Howlader N, Noone A, Krapcho M, et al. SEER Cancer Statistics
Review, 1975-2016. Bethesda, MD: National Cancer Institute. In:2019.
38. Banegas MP, Guy Jr GP, de Moor JS, et al. For working-age cancer
survivors, medical debt and bankruptcy create financial hardships.Health Affairs. 2016;35(1):54-61.
39. Mehnert A. Employment and work-related issues in cancer survivors.Critical reviews in oncology/hematology. 2011;77(2):109-130.
40. Steiner JF, Cavender TA, Main DS, Bradley CJ. Assessing the impact
of cancer on work outcomes. Cancer. 2004;101(8):1703-1711.
41. Ekwueme DU, Yabroff KR, Guy Jr GP, et al. Medical costs and
productivity losses of cancer survivors—United States, 2008–2011.MMWR Morbidity and mortality weekly report. 2014;63(23):505.
42. Health Insurance Coverage of the Total Population. 2018;
https://www.kff.org/other/state-indicator/total-population/?currentTimeframe=0&sortModel=%7B%22colId%22:%22Location%22,%22sort%22:%22asc%22%7D.
Accessed April 8, 2020.
43. Kirchhoff AC, Nipp R, Warner EL, et al. “Job lock” among long-term
survivors of childhood cancer: a report from the Childhood Cancer
Survivor Study. JAMA oncology. 2018;4(5):707-711.
44. Blinder VS, Gany FM. Impact of Cancer on Employment. Journal
of clinical oncology: official journal of the American Society of
Clinical Oncology. 2020;38(4):302.
45. Garfield R, Orgera K, Damico A. The Coverage Gap: Uninsured Poor
Adults in States that Do Not Expand Medicaid. January 2020. Accessed
April 8, 2020.
46. Cost-Sharing for Plans Offered in the Federal Msrketplace,
2014-2020. December 9, 2019;
https://www.kff.org/slideshow/cost-sharing-for-plans-offered-in-the-federal-marketplace-2014-2020/.
Accessed April 8, 2020.
47. Fehr R, Kamal R, Cox C. How ACA Marketplace Premiums Are Changing by
County in 2020. November 7, 2019;
https://www.kff.org/health-costs/issue-brief/how-aca-marketplace-premiums-are-changing-by-county-in-2020/.
Accessed April 8, 2020.
48. Pollitz K. What People (and Policymakers) Can Do About Losing
Coverage During the COVID-19 Crisis. March 27, 2020;
https://www.kff.org/coronavirus-policy-watch/what-people-and-policymakers-can-do-about-losing-coverage-during-the-covid-19-crisis/.
Accessed April 8, 2020.
49. Senior K. Battling cancer and the recession. Lancet Oncol.2009;10(3):212-213.
50. Woolhandler S, Himmelstein DU. Intersecting U.S. Epidemics: COVID-19
and Lack of Health Insurance. Annals of Internal Medicine. 2020.
51. Kaisaeng N, Harpe SE, Carroll NV. Out-of-pocket costs and oral
cancer medication discontinuation in the elderly. Journal of
Managed Care Pharmacy. 2014;20(7):669-675.
52. de Souza JA, Kung S, O’Connor J, Yap BJ. Determinants of
patient-centered financial stress in patients with locally advanced head
and neck cancer. Journal of oncology practice.2017;13(4):e310-e318.
53. Costas-Muniz R, Leng J, Aragones A, et al. Association of
socioeconomic and practical unmet needs with self-reported nonadherence
to cancer treatment appointments in low-income Latino and Black cancer
patients. Ethnicity & health. 2016;21(2):118-128.
54. Streeter SB, Schwartzberg L, Husain N, Johnsrud M. Patient and plan
characteristics affecting abandonment of oral oncolytic prescriptions.Journal of oncology practice. 2011;7(3S):46s-51s.
55. Ennis KY, Chen M-H, Smith GC, et al. The Impact of Economic
Recession on the Incidence and Treatment of Cancer. J Cancer.2015;6(8):727-733.
56. Zheng Z, Jemal A, Tucker-Seeley R, et al. Worry About Daily
Financial Needs and Food Insecurity Among Cancer Survivors in the United
States. 2020;18(3):315.
57. Maruthappu M, Watkins J, Noor AM, et al. Economic downturns,
universal health coverage, and cancer mortality in high-income and
middle-income countries, 1990-2010: a longitudinal analysis.Lancet. 2016;388(10045):684-695.
58. Jahoda M. Economic recession and mental health: Some conceptual
issues. Journal of social Issues. 1988;44(4):13-23.
59. Lewis G, Sloggett A. Suicide, deprivation, and unemployment: record
linkage study. BMJ. 1998;317(7168):1283-1286.
60. Reeves A, McKee M, Stuckler D. Economic suicides in the Great
Recession in Europe and North America. British Journal of
Psychiatry. 2014;205(3):246-247.
61. Misono S, Weiss NS, Fann JR, Redman M, Yueh B. Incidence of suicide
in persons with cancer. Journal of clinical oncology : official
journal of the American Society of Clinical Oncology.2008;26(29):4731-4738.
62. Zaorsky NG, Zhang Y, Tuanquin L, Bluethmann SM, Park HS, Chinchilli
VM. Suicide among cancer patients. Nat Commun. 2019;10(1):207.
63. Osazuwa-Peters N, Simpson MC, Zhao L, et al. Suicide risk among
cancer survivors: Head and neck versus other cancers. Cancer.2018;124(20):4072-4079.
64. Katz MS. Cancer Care in the Time of COVID-19. 2020;
https://connection.asco.org/blogs/cancer-care-time-covid-19?cid=DM4800&bid=40974521.
Accessed March 31, 2020.
65. Yabroff KR, Bradley C, Shih Y-CT. Understanding financial hardship
among cancer survivors in the United States: Strategies for prevention
and mitigation. Journal of Clinical Oncology. 2019:JCO. 19.01564.
66. Powell VD, Silveira MJ. What Should Palliative Care’s Response be to
the COVID-19 Epidemic? Journal of Pain and Symptom Management.
67. Fausto J, Hirano L, Lam D, et al. Creating a Palliative Care
Inpatient Response Plan for COVID19 - The UW Medicine Experience.J Pain Symptom Manage. 2020.
68. Calton B, Abedini N, Fratkin M. Telemedicine in the Time of
Coronavirus. J Pain Symptom Manage. 2020.